Recent Finacing
Recent Raise
Cantai Therapeutics develops cytokine-targeting bispecific antibodies for autoimmune and inflammatory diseases, leveraging Alloy Therapeutics’ ATX-CLC common light chain mouse and 82VS antibody discovery platforms.
Focus Areas
Recent Investors
Funding round
Investors
